Difference in the Pharmacokinetics and Hepatic Metabolism of Antidiabetic Drugs in Zucker Diabetic Fatty and Sprague-Dawley Rats.
about
Changes in drug transport and metabolism and their clinical implications in non-alcoholic fatty liver disease.Tissue Specific Modulation of cyp2c and cyp3a mRNA Levels and Activities by Diet-Induced Obesity in Mice: The Impact of Type 2 Diabetes on Drug Metabolizing Enzymes in Liver and Extra-Hepatic Tissues.Influence of the pharmacokinetic profile on the plasma glucose lowering effect of the PPARγ agonist pioglitazone in Wistar fatty rats.Ticagrelor and Rosuvastatin Have Additive Cardioprotective Effects via Adenosine.Influence of diabetes on plasma pharmacokinetics and brain bioavailability of grape polyphenols and their phase II metabolites in the Zucker diabetic fatty rat.
P2860
Difference in the Pharmacokinetics and Hepatic Metabolism of Antidiabetic Drugs in Zucker Diabetic Fatty and Sprague-Dawley Rats.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Difference in the Pharmacokine ...... Fatty and Sprague-Dawley Rats.
@en
Difference in the Pharmacokine ...... Fatty and Sprague-Dawley Rats.
@nl
type
label
Difference in the Pharmacokine ...... Fatty and Sprague-Dawley Rats.
@en
Difference in the Pharmacokine ...... Fatty and Sprague-Dawley Rats.
@nl
prefLabel
Difference in the Pharmacokine ...... Fatty and Sprague-Dawley Rats.
@en
Difference in the Pharmacokine ...... Fatty and Sprague-Dawley Rats.
@nl
P2093
P2860
P356
P1476
Difference in the Pharmacokine ...... Fatty and Sprague-Dawley Rats.
@en
P2093
David W Bedwell
Jeff W Cramer
Kenneth C Cassidy
Kenneth J Ruterbories
Lisa A Adams
Luc R A Rougée
Michael A Mohutsky
Nathan A Calvert
Nathan P Yumibe
Richard D Moulton
P2860
P304
P356
10.1124/DMD.116.070623
P577
2016-05-23T00:00:00Z